![logo](/logos/002082.SZ.webp)
Wanbangde Pharmaceutical Holding Group Co., Ltd.
SZSE:002082.SZ
6.52 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,541.939 | 1,786.428 | 1,930.602 | 13,701.856 | 15,794.901 | 14,335.31 | 14,635.458 | 9,183.466 | 11,572.198 | 11,451.694 | 11,786.336 | 10,972.922 | 10,873.866 | 8,053.707 | 6,347.707 | 5,835.868 | 4,891.602 | 3,738.956 | 1,172.65 | 535.416 | 416.033 |
Cost of Revenue
| 907.265 | 847.299 | 981.877 | 12,348.141 | 15,085.246 | 13,813.033 | 14,409.09 | 9,008.636 | 11,389.324 | 11,179.926 | 11,513.557 | 10,732.619 | 10,546.196 | 7,735.521 | 6,085.243 | 5,639.988 | 4,737.731 | 3,616.821 | 1,101.805 | 468.693 | 369.535 |
Gross Profit
| 634.674 | 939.129 | 948.725 | 1,353.714 | 709.654 | 522.278 | 226.368 | 174.83 | 182.873 | 271.768 | 272.78 | 240.304 | 327.67 | 318.186 | 262.464 | 195.881 | 153.871 | 122.135 | 70.845 | 66.723 | 46.497 |
Gross Profit Ratio
| 0.412 | 0.526 | 0.491 | 0.099 | 0.045 | 0.036 | 0.015 | 0.019 | 0.016 | 0.024 | 0.023 | 0.022 | 0.03 | 0.04 | 0.041 | 0.034 | 0.031 | 0.033 | 0.06 | 0.125 | 0.112 |
Reseach & Development Expenses
| 53.984 | 59.105 | 76.196 | 184.891 | 119.725 | 99.604 | 21.73 | 43.357 | 49.554 | 44.501 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 46.469 | 52.329 | 64.723 | 90.603 | 71.903 | 65.59 | 40.877 | 21.161 | 22.6 | 21.575 | 20.204 | 28.682 | 28.231 | 24.323 | 63.899 | 46.393 | 26.344 | 31.436 | 20.077 | 9.753 | 6.611 |
Selling & Marketing Expenses
| 280.59 | 398.986 | 393.447 | 436.942 | 83.357 | 70.649 | 30.987 | 31.32 | 34.011 | 72.549 | 58.524 | 35.091 | 40.633 | 36.809 | 34.088 | 25.329 | 18.871 | 12.998 | 8.002 | 4.468 | 2.962 |
SG&A
| 327.059 | 451.316 | 458.169 | 527.545 | 155.26 | 136.239 | 71.864 | 52.481 | 56.611 | 94.124 | 78.728 | 63.772 | 68.864 | 61.133 | 97.986 | 71.722 | 45.215 | 44.435 | 28.079 | 14.221 | 9.573 |
Other Expenses
| 2.933 | 140.76 | 118.83 | 148.186 | 109.234 | -2.902 | 1.389 | 6.217 | 5.555 | 3.79 | 3.583 | 1.7 | -0.15 | 0.639 | 0.764 | -1.707 | 1.199 | -0.727 | -1.225 | -0.273 | -0.774 |
Operating Expenses
| 524.273 | 651.181 | 653.195 | 860.622 | 384.219 | 349.327 | 143.808 | 100.787 | 101.013 | 139.474 | 125.924 | 106.545 | 111.347 | 117.517 | 104.197 | 76.525 | 47.689 | 46.327 | 29.642 | 15.608 | 10.694 |
Operating Income
| 26.998 | 268.058 | 512.685 | 513.22 | 263.101 | 146.057 | 116.911 | 77.647 | 80.829 | 132.4 | 139.059 | 110.006 | 200.248 | 193.761 | 151.778 | 95.664 | 86.587 | 57.265 | 28.688 | 39.831 | 30.944 |
Operating Income Ratio
| 0.018 | 0.15 | 0.266 | 0.037 | 0.017 | 0.01 | 0.008 | 0.008 | 0.007 | 0.012 | 0.012 | 0.01 | 0.018 | 0.024 | 0.024 | 0.016 | 0.018 | 0.015 | 0.024 | 0.074 | 0.074 |
Total Other Income Expenses Net
| 2.933 | -167.925 | -151.55 | -165.463 | -0.518 | -29.796 | 35.739 | 7.343 | 1.095 | 3.284 | -5.231 | -22.053 | -16.319 | -6.372 | -6.038 | -25.554 | -18.397 | -20.667 | -13.794 | -11.689 | -5.882 |
Income Before Tax
| 29.932 | 100.133 | 361.135 | 347.757 | 262.583 | 143.155 | 118.299 | 81.386 | 82.955 | 135.578 | 141.625 | 111.706 | 200.005 | 194.297 | 152.23 | 93.802 | 87.785 | 55.84 | 27.436 | 39.491 | 30.045 |
Income Before Tax Ratio
| 0.019 | 0.056 | 0.187 | 0.025 | 0.017 | 0.01 | 0.008 | 0.009 | 0.007 | 0.012 | 0.012 | 0.01 | 0.018 | 0.024 | 0.024 | 0.016 | 0.018 | 0.015 | 0.023 | 0.074 | 0.072 |
Income Tax Expense
| 3.605 | 25.81 | 199.976 | 55.545 | 53.751 | 17.966 | 17.889 | 8.001 | 14.521 | 22.229 | 24.368 | 20.763 | 37.544 | 38.821 | 29.151 | 18.258 | 22.762 | 19.004 | 6.874 | 13.637 | 9.81 |
Net Income
| 49.209 | 74.323 | 166.51 | 284.936 | 157.029 | 84.08 | 98.213 | 69.736 | 63.025 | 107.531 | 111.558 | 86.409 | 158.644 | 151.986 | 121.048 | 74.047 | 63.614 | 32.85 | 21.383 | 25.674 | 20.235 |
Net Income Ratio
| 0.032 | 0.042 | 0.086 | 0.021 | 0.01 | 0.006 | 0.007 | 0.008 | 0.005 | 0.009 | 0.009 | 0.008 | 0.015 | 0.019 | 0.019 | 0.013 | 0.013 | 0.009 | 0.018 | 0.048 | 0.049 |
EPS
| 0.08 | 0.12 | 0.27 | 0.47 | 1.24 | 0.35 | 0.41 | 0.29 | 0.26 | 0.45 | 0.47 | 0.36 | 0.67 | 0.64 | 0.51 | 0.32 | 0.3 | 0.23 | 0.16 | 0.26 | 0.21 |
EPS Diluted
| 0.08 | 0.12 | 0.27 | 0.47 | 1.24 | 0.35 | 0.41 | 0.29 | 0.26 | 0.45 | 0.47 | 0.36 | 0.67 | 0.64 | 0.51 | 0.32 | 0.3 | 0.23 | 0.16 | 0.26 | 0.21 |
EBITDA
| 209.521 | 375.091 | 607.662 | 620.332 | 397.652 | 240.139 | 141.251 | 142.69 | 150.558 | 199.612 | 215.764 | 199.775 | 272.163 | 257.727 | 208.225 | 158.281 | 140.074 | 106.113 | 56.73 | 58.559 | 46.266 |
EBITDA Ratio
| 0.136 | 0.21 | 0.315 | 0.045 | 0.025 | 0.017 | 0.01 | 0.016 | 0.013 | 0.017 | 0.018 | 0.018 | 0.025 | 0.032 | 0.033 | 0.027 | 0.029 | 0.028 | 0.048 | 0.109 | 0.111 |